A Response to: Letter to the Editor Regarding "Comparing Cardiovascular Outcomes and Costs of Perindopril-, Enalapril- or Losartan-Based Antihypertensive Regimens in South Africa: Real-World Medical Claims Database Analysis"

被引：0

作者：

Snyman, Jacques R. ^{[1
]}

Gumedze, Freedom ^{[1
]}

Jones, Erika S. W. ^{[2
,3
]}

Alaba, Olufunke A. ^{[4
]}

Tsabedze, Nqoba ^{[5
,6
]}

Vira, Alykhan ^{[7
]}

Ntusi, Ntobeko A. B. ^{[3
,8
,9
,10
,11
]}

机构：

[1] Univ Cape Town, Dept Stat Sci, Cape Town, South Africa

[2] Univ Cape Town, Dept Med, Div Nephrol & Hypertens, Cape Town, South Africa

[3] Groote Schuur Hosp, Cape Town, South Africa

[4] Univ Cape Town, Sch Publ Hlth & Family Med, Hlth Econ Unit, Cape Town, South Africa

[5] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Div Cardiol,Dept Internal Med, Johannesburg, South Africa

[6] Charlotte Maxeke Johannesburg Acad Hosp, Johannesburg, South Africa

[7] Quantium Hlth South Africa, Johannesburg, South Africa

[8] Univ Cape Town, Div Cardiol, Dept Med, Cape Town, South Africa

[9] Univ Cape Town, Cape Heart Inst, Fac Hlth Sci, Cape Town, South Africa

[10] South African Med Res Council, Cape Town, South Africa

[11] African Res Univ Alliance, Guild European Res Intens Univ Cluster Res Excelle, Brussels, Belgium

来源：

ADVANCES IN THERAPY | 2025年 / 42卷 / 01期

关键词：

Hypertension; Real-world evidence; Medical costs; Efficacy; South Africa;

D O I：

10.1007/s12325-024-03045-y

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：552 / 555

页数：4

共 11 条

[1]

[Anonymous], 2023, Real-World Evidence

[2]

[Anonymous], 2019, Reproducibility and Replicability in Science

[3] Real-World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe [J].

Cave, Alison ;

Kurz, Xavier ;

Arlett, Peter .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (01) :36-39

[4]

Cavlan Olivia, 2018, Real-World Evidence: From Activity to Impact in Healthcare Decision Making

[5] Real-World Evidence: A Primer [J].

Dang, Amit .

PHARMACEUTICAL MEDICINE, 2023, 37 (01) :25-36

[6]

de Lusignan Simon, 2015, J Innov Health Inform, V22, P368, DOI [10.14236/jhi.v22i3.177, 10.14236/jhi.v22i3.177]

[7] Letter to the Editor Regarding "Comparing Cardiovascular Outcomes and Costs of Perindopril-, Enalapril- or Losartan-Based Antihypertensive Regimens in South Africa: Real-World Medical Claims Database Analysis" [J].

Leong, Trudy D. ;

Ebrahim, Sumayyah ;

Kredo, Tamara .

ADVANCES IN THERAPY, 2025, 42 (01) :548-551

[8] Natural History and Real-World Data in Rare Diseases: Applications, Limitations, and Future Perspectives [J].

Liu, Jing ;

Barrett, Jeffrey S. ;

Leonardi, Efthimia T. ;

Lee, Lucy ;

Roychoudhury, Satrajit ;

Chen, Yong ;

Trifillis, Panayiota .

JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 :S38-S55

[9] Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer [J].

Saesen, Robbe ;

Van Hemelrijck, Mieke ;

Bogaerts, Jan ;

Booth, Christopher M. ;

Cornelissen, Jan J. ;

Dekker, Andre ;

Eisenhauer, Elizabeth A. ;

Freitas, Andre ;

Gronchi, Alessandro ;

Hernan, Miguel A. ;

Hulstaert, Frank ;

Ost, Piet ;

Szturz, Petr ;

Verkooijen, Helena M. ;

Weller, Michael ;

Wilson, Roger ;

Lacombe, Denis ;

van der Graaf, Winette T. .

EUROPEAN JOURNAL OF CANCER, 2023, 186 :52-61

[10] Comparing Cardiovascular Outcomes and Costs of Perindopril-, Enalapril- or Losartan-Based Antihypertensive Regimens in South Africa: Real-World Medical Claims Database Analysis [J].

Snyman, Jacques R. ;

Gumedze, Freedom ;

Jones, Erika S. W. ;

Alaba, Olufunke A. ;

Tsabedze, Nqoba ;

Vira, Alykhan ;

Ntusi, Ntobeko A. B. .

ADVANCES IN THERAPY, 2023, 40 (11) :5076-5089

← 1 2 →